http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-287852-A7
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c986d997e1f61f2bc6f4b7f09e16da63 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-78 |
| filingDate | 1989-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_394821a2b05996fad20d81a08c78b7e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82a50c59eaf5816f2221d275b2a0e2b2 |
| publicationDate | 1991-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DD-287852-A7 |
| titleOfInvention | PROCESS FOR DETERMINING THE FREE THYROXIN IN BLOOD SERUM |
| abstract | The invention relates to a method for determining the "free", d. H. biologically active thyroxine (FT4) in the blood serum according to the principle of the analog tracer and solves the task as far as possible to prevent the binding of the analog tracer to Albuminmolekuele. This is achieved by adding to the sample an albumin binding inhibitor (drug with blood lipid lowering activity or sulfonamides with prolonged action) in the concentration range of 0.1 to 1.0 mg per 0.1 ml of serum. {Thyroxine; free thyroxine; Blood serum; Analog tracer; Albumin; Binding inhibitor} |
| priorityDate | 1989-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.